Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
Case report
[키워드] acute respiratory syndrome
association
B-cell
B-cell-depleted patient
chest pain
coronavirus
coronavirus disease
Coronavirus disease 2019
CoV-2-S-ABSARS-CoV-2 S protein antibodies
COVID-19
COVID-19coronavirus disease 2019
Ctcycle threshold
cycle threshold
Dyspnea
fatigue
Follow-up
higher risk
Infection
inflammation marker
infusion
initial
Long term oxygen therapy
LTOTLong term oxygen therapy
mABsmonoclonal antibodies
monoclonal
monoclonal antibodies
monoclonal antibody
Mortality
Patient
PCRpolymerase chain reaction
polymerase chain reaction
positive
positive serum antibodies
Prolonged infection
remained
SARS-CoV-2
SARS-CoV-2 antibody
SARS-CoV-2 S protein antibodies
SARS-CoV-2Severe acute respiratory syndrome coronavirus type2
Severe acute respiratory syndrome coronavirus type2
Sotrovimab
Swab
swabs
Symptom
Symptoms
symptoms of COVID-19
treated
viral clearance
[DOI] 10.1016/j.idcr.2022.e01528 [Article Type] Case report
[DOI] 10.1016/j.idcr.2022.e01528 [Article Type] Case report